Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...
Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...
Medical history has recently been made in a New York City hospital. This month, 21-year-old Sebastien Beauzile became the ...
Scientists have discovered more than a dozen genes that regulate the production of fetal hemoglobin in people of African ...
A recent Vanderbilt study has found a cure for sickle cell disease, a blood disorder where the body creates mutated red blood ...
We came across a bullish thesis on CRISPR Therapeutics AG (CRSP) on wallstreetbets Subreddit Page by MADD-Scientis. In this ...
The launching of the Sentara-Eastern Virginia Medical School Comprehensive Sickle Cell Program in October gave adults ...
CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...
For teenagers with sickle cell disease, these years can be even more challenging due to the impact of chronic pain, fatigue, hospital visits, and lifestyle restrictions. SCD is a genetic blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback